Atlas Trials

Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects

Clinical trial NCT00295022 · COMPLETED

Trial details

NCT number
NCT00295022
Sponsor
UCB S.A. - Pharma Sector
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Rhinitis, Allergic, Seasonal
Start date
2006-07-29
Primary completion
2006-10-01
Enrollment
418

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.